ClinicalTrials.Veeva

Menu

Feasibility of Remotely Measured Activity Behavior for Individuals With Functional Neurologic Disorder

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status

Not yet enrolling

Conditions

Functional Neurological Disorder

Study type

Observational

Funder types

Other

Identifiers

NCT07478666
COMIRB 25-2380

Details and patient eligibility

About

This study evaluates whether remotely measured daily activity behavior, captured through a thigh-worn accelerometer, can serve as a reliable and ecologically valid indicator of symptom impact in individuals with Functional Neurologic Disorder (FND). Current clinician-rated assessments capture only a single time point and do not reflect day-to-day symptom variability or functional impact. The study will (1) assess the feasibility of continuous activity monitoring in people with FND, (2) examine associations between activity behavior and established clinician- and patient-reported FND measures, and (3) qualitatively explore participants' lived experiences of daily activity. Findings aim to address a critical gap in understanding real-world function in this heterogeneous population.

Full description

Specific Aim 1:

Evaluate the feasibility of remotely assessed activity behavior with thigh-mounted accelerometry in 20 individuals with FND.

The feasibility of remotely assessed activity behavior in participants with FND will be determined based on: 1) enrollment of 20 participants with FND within 10 months, 2) ≥90% adherence to thigh-mounted accelerometer use based on wear time of ≥ 5 days, 3) retaining ≥90% participants with FND at Visit 2, and 4) ≥90% acceptability calculated as the proportion of participants with a response of 'somewhat agree' or better on a 7-point Likert scale asking about acceptability of the study procedures.

Specific Aim 2:

Determine differences in activity behaviors between people with functional neurologic disorder and healthy controls (CTL) over 7-10 days.

Physical activity will be measured by an accelerometer-based activity monitor (activPAL4, PAL Technologies). The thigh-mounted activPAL will be worn continuously for 7 days between visit 1 and visit 2. Primary variables of interest will include mean daily step count, total sedentary time, bouts of sedentary time > 30 min, and number of transitions to standing, and time standing and stepping in order to capture a full picture of free-living mobility and activity.

Specific Aim 3:

Explore the lived experiences of activity behavior in people with FND. Approach: Conduct individual, semi-structured interviews to explore the impact of FND symptoms on activity behavior and integrate these findings with quantitative activity measures to understand the influence on real-world activity.

Aim 3: The lived experience of activity behavior for people with FND will be assessed using a mixed-methods approach. Qualitative data will be analyzed using thematic analysis with deductive and inductive coding to develop qualitative interview themes. Quantitative activity behavior and qualitative interview data will be analyzed together to develop a more comprehensive understanding of the impact of FND on activity behavior.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Participants with FND:

•Neurologist-confirmed diagnosis of functional neurologic disorder with motor symptoms, sensory symptoms, dizziness, and/or seizures

Healthy Controls:

  • Roughly matched to participants with FND for age and sex
  • Free from major disease that affects mobility (e.g., neurologic, movement, cardiac, pulmonary, renal, and psychiatric disorders) by history.

Exclusion criteria

Participants with FND

  • Physical or cognitive symptoms impairing ability to engage with the protocol (e.g., seizure frequency > 10/day).
  • Diagnosis of other major neurologic, cardiovascular, musculoskeletal, or psychiatric disorder that affects mobility as determined by the principal investigator

Trial design

40 participants in 2 patient groups

People with FND
Description:
Individuals aged 18-65 with neurologist confirmed functional neurological disorder
Healthy Controls
Description:
Individuals aged 18-65 who are roughly matched to people with FND for age and sex and free from major disease that affects mobility.

Trial contacts and locations

0

Loading...

Central trial contact

Elliot J Gann, DPT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems